Open AccessCharacterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care
Author(s) -
Frank Behrens,
GerdRüdiger Burmester,
Martin Feuchtenberger,
Herbert Kellner,
Cornelia Kuehne,
Anke Liebhaber,
Siegfried Wassenberg,
Johannes Gerlach,
Max Zortel,
Michael Hofmann,
C. Amberger
Publication year - 2022
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/yu55rd
Subject(s) - medicine , tocilizumab , depression (economics) , rheumatoid arthritis , adverse effect , beck depression inventory , repeated measures design , physical therapy , psychiatry , anxiety , statistics , mathematics , economics , macroeconomics
To assess whether tocilizumab treatment is associated with changes in depression symptoms in patients with rheumatoid arthritis (RA) during routine daily care.